Quality of reporting in oncology studies: A systematic analysis of literature reviews and prospects.
The present review gives an overview of systematic reviews published in peer reviewed Journals analysing quality of reporting in oncology studies. PUBMED and Cochrane library were searched to identify systematic reviews assessing quality of reporting for randomized controlled trials (RCTs) and observational studies (OBS). Recommendations and primary endpoints used to assess the quality of reporting were described. Intrinsic quality of reporting was analyzed using an Overall Quality Score for literature Reviews (OQSR). Main evaluation themes were overall quality of reporting (20/58) and reporting of Health-Related Quality Of Life (HRQOL) in RCTs (7/58). Reporting recommendations used were not detailed in 56.9% of reviews. Insufficient reporting for the methodological description (randomization, blinding details, and allocation concealment) and the rationale for using specific measure of HRQOL were highlighted. OQSR was significantly higher for reviews published between 2010 and 2014 (after the PRISMA Publication), as compared to those published between 1996-2009 (median OQSR 10 (10-11) versus median OQSR 9 (6-10) respectively, p=0.0053). Intrinsic quality of reporting is satisfactory and has been improved in the last years.
Department of Medical Oncology, Lucien Neuwirth Cancer Institute, Saint Priest-En-Jarez, France. Electronic address: romain.rivoirard@icloire.fr.
Romain
R
Rivoirard
Hygee Center, Regional Center for Cancer Prevention, CIC 1408, Saint Priest en Jarez, France; EMR3738, Ciblage Thérapeutique en Oncologie, Claude Bernard University, Lyon, France.
Aurélie
A
Bourmaud
Hygee Center, Regional Center for Cancer Prevention, CIC 1408, Saint Priest en Jarez, France; Jean Monnet University, Saint-Etienne, France.
Mathieu
M
Oriol
Hygee Center, Regional Center for Cancer Prevention, CIC 1408, Saint Priest en Jarez, France.
Fabien
F
Tinquaut
Department of Medical Oncology, Lucien Neuwirth Cancer Institute, Saint Priest-En-Jarez, France.
Benoîte
B
Méry
Department of Radiotherapy, Lucien Neuwirth Cancer Institute, Saint Priest-En-Jarez, France.
Julien
J
Langrand-Escure
Department of Radiotherapy, Lucien Neuwirth Cancer Institute, Saint Priest-En-Jarez, France.
Alexis
A
Vallard
Department of Medical Oncology, Lucien Neuwirth Cancer Institute, Saint Priest-En-Jarez, France.
Pierre
P
Fournel
Jean Monnet University, Saint-Etienne, France; Department of Radiotherapy, Lucien Neuwirth Cancer Institute, Saint Priest-En-Jarez, France; EMR3738, Laboratoire de Radiobiologie Cellulaire et Moléculaire, Claude Bernard University, Lyon, France.
Nicolas
N
Magné
Hygee Center, Regional Center for Cancer Prevention, CIC 1408, Saint Priest en Jarez, France; EMR3738, Ciblage Thérapeutique en Oncologie, Claude Bernard University, Lyon, France; Jean Monnet University, Saint-Etienne, France.
Franck
F
Chauvin
D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D012196:Review Literature as Topic
Data reporting; Observational study; Oncology; Randomized controlled trial; Review